Momentum & Growth

4 OTC Stocks to Watch This Year: ENZC HMBL ILST SANP

Smart investors know that if you want to make the big money off a small account, the place to be is the OTC Markets. There are many good OTC stocks that can boost your portfolio’s value in the long term. For investors, we preach the key to trading penny stocks is finding momentum BEFORE it happens and ahead of the crowd.

We alert our subscribers with our best ideas before our regular readers. This is the value of having a subscription to Insider Financial, which you can sign up for here.

If you watch the Insider Financial YouTube channel, you can get a sense of the ideal time to book profits. We warned our subscribers not to get greedy or get caught up in the diamond hands/paper hands BS.

We also recommend you own a portfolio of penny stocks. For some, that can be as many as 10 to 20 or more OTC stocks. This provides diversification and allows one to manage the market’s moods much easier.

In this article, we look at 4 OTC stocks with great potential this year. Three of them are planning or conducting M&A deals and are poised to expand rapidly next year. The Pink Current stocks are Enzolytics Inc (OTCPK: ENZC), HUMBL, Inc (OTCPK: HMBL), International Star, Inc (OTCPK: ILST), and Santo Mining Corporation (OTCPK: SANP).

OTC stocks #1 ENZC

OTC stocks #2 HMBL

OTC stocks #3 ILST

OTC stocks #4 SANP

OTC STOCKS #1 ENZC

Enzolytics Inc has had a great week, managing to bounce back from the lowest level in about a year. The OTC stock, which we have recommended again and again, has gained over 70% during the last five trading sessions, currently trading at the highest level since the end of November at $0.11. ENZC is down about 90% from the 2021’s peak, so there is much room for growth and this is a great time to buy the dip.

We got our subscribers in on ENZC last year in October at just $.014 a share, helping many of our subscribers secure profits when the stock almost hit the $1 mark in February last year. We anticipate another rally this year, as the company has been working on multiple therapies and has pending patents.

ENZC patented anti-HIV therapeutics and uses its proprietary methodology to produce human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. You can read here why we think ENZC’s HIV therapeutics are better than Gilead’s products that have monopolized the space.

Besides HIV, ENZC applies its proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases, including HIV, influenza A, influenza B, rabies, tetanus, diphtheria, and even the coronavirus causing COVID-19.

ENZC is also using AI to identify immutable sites on 20 viruses, including COVID.

The latest price spike came after ENZC announced that it had engaged Scendea USA, Inc, a leading international product development and regulatory consulting group, to advance its anti-HIV therapeutic ITV-1 to production, clinical trials, and market approval under both the European Medicines Act (EMA) and the US FDA regulatory process.

Scendea’s service will focus on reducing time-to-market and minimizing development costs.

Enzolytics Inc. currently has in place engagements for the product production by Danhson and clinical trials at Clinic Design to advance its anti-HIV therapeutic ITV-1 to the final stage of regulatory approval by the European Medicines Agency (EMA), leading to patient use authorization. Additionally, Scendea will also assist with the FDA approval process to expeditiously introduce ITV-1 to the North American market.

On January 4, ENZC reiterated its plans related to the production and sale of Enzolytics IPF Immune™ in the US and North America. The product is a liquid nutritional supplement that acts to strengthen the body’s immune system. The active components in the supplement have been registered with the FDA for use in the US under NDI Reg. No. 1083, and the immune booster is being produced and sold pursuant to the EZNC’s exclusive North America license under US Patent No. 8,309,072.

ENZC has engaged a national marketing and branding agency as its distributor to advance the product through multiple distribution channels throughout the US. The company will significantly benefit from the extensive capacity of the agency to place this product in major outlets, large and small, throughout the country.

ENZC is a $340 million company that stays on a pile of patents and has some great potential, which makes us think that it’s undervalued and should trade at least near the $1 dollar mark for now. We expect a bullish first half of the year as the company is moving to production and marketing of its products.

OTC STOCKS #2 HMBL

HUMBL, Inc is another great Pink Current stock that you can buy for cheap. It is currently trading at $0.27, up 5% for the week and down 33% during the last month. In fact, the OTC stock is trading close to the lowest level in a year, giving you the opportunity to buy the dip. Judging by volume figures at the end of December, HMBL has been under great pressure from bears, which makes it a hidden short squeeze candidate.

We discussed HMBL in a dedicated article in November 2020, shortly after the company became public as a result of a merger. Anyone that bought on the back of overage at $.027 and held into February would have seen potential gains of over 28,000%! This is another example demonstrating why you should consider subscribing to Insider Financial.

HUMBL is a web 3 platform whose goal is to connect consumers and merchants in the digital economy across its HUMBL Mobile Applications, HUMBL Marketplace, and HUMBL Financial divisions. HUMBL Mobile Applications deliver more seamless global transactions, by integrating multiple currencies, payment methods, and financial services.

HUMBL Marketplace was developed to connect customers and merchants online, in improved global commerce, deal discovery, and blockchain tokenization programs. HUMBL Financial has developed new software and algorithms for the digital asset trading markets, which represent a new global market for blockchain technologies, and will also offer other credit, lending and financial services, although the products are not available in the US and a few other jurisdictions.

At the end of last year, George Sharp returned to HMBL as Capital Markets Advisor to help it advance to the OTCQB tier and then towards an application to the NASDAQ Stock Market. In furtherance of these milestones, the company will file audited financials with the SEC, beginning with the yearend statement for 2021. He recently pointed the fingers are shorts, which wrongly believed that an institutional investor dumped its HMBL stock.

Interestingly, HMBL is also the parent of Monster Creative, which recently announced today that it has won two awards at the 2021 Clio Awards, as well as one nomination. The 2021 edition saw Monster Creative secure wins for:

  • Theatrical: Trailer – Action/Adventure: 6 Underground (Silver Winner)
  • Theatrical: Trailer – Documentary: Val (Bronze Winner)
  • Theatrical: Partnerships Branded Content Video: 6 Underground + Alfa Romeo (Shortlist)

Released by Netflix on December 13, 2019, with a budget of $150 million, 6 Underground is one of the most expensive Netflix Originals ever created. The film stars Ryan Reynolds and was viewed by 83 million member households within the first four weeks of its release.

Still, HMBL should be ready that the greatest part of the revenue to come from its blockchain/web 3 ecosystem. In November, HMBL announced the newest release of the ‘HUMBL Pay’ mobile wallet, including the latest upgrades to its P2P functionalities, and additional features that simplify the management of digital assets and blockchain functionality. HUMBL Pay users can buy cryptocurrencies via major credit cards inside the HUMBL Pay mobile wallet, transfer cryptocurrencies between HUMBL mobile wallets, earn as much as 7% interest on various digital assets. Last month, HUMBL Pay launched the ACH integration.

HMBL taps into one of the fastest-growing industries and has some great products to offer. It’s also an NFT play. As soon as revenue starts showing up this year, be ready for a rebound in the stock price.

OTC STOCKS #3 ILST

International Star, Inc is a small company that has recently changed business direction and is ready to start a new journey, which often comes with great opportunities for early investors. The stock got the Pink Current status a few months ago. The share price is now trading at $0.015, up 50% over the month and not far from the highest level in many years that was set in October at over two pennies.

The $28 million company historically focused on mineral property interests, but it recently shifted its business focus to fintech, Decentralized Finance (DeFi), blockchain, metaverse, non-fungible tokens (NFTs), crypto and gaming industry. In other words, everything that grows exponentially these days is an opportunity for ILST.

The company said that the first merger had already been finalized and waiting for rollout, although we still don’t know names and details. ILST is also moving ahead by evaluating various acquisition candidates. The strategic objective being to built a robust top-level finance, technology and blockchain enterprise that consistently creates and build stakeholders’ value.

ILST has a great share structure, with outstanding shares making accounting for about 66% of the authorized shares.

Note that ILST is only making the first steps now, and it can turn into something huge. Getting exposure at less than two pennies is the real deal. This may become another OWUV, which was the biggest winner for our subscribers in 2021 and can grow further.

OTC STOCKS #4 SANP

Santo Mining Corporation is another mineral exploration company that turned into a blockchain play, although it apparently maintains its business related to gold and other mineral resources in the Dominican Republic.

On December 28, the share price extended losses to touch the lowest level in about a year, but SANP then quickly rebounded and has more than tripled since then. At the time of writing, you can buy SANP stock for $0.0019 per share. In February, the stock surged to over two pennies before correcting for months.

Today, SANP is promoting itself as a vertically integrated blockchain and cryptocurrency development company with corporate subsidiaries in Vietnam and the Republic of Panama. It manages, operates, and develops end-to-end Blockchain-as-a-Service, which lets businesses get applications up and running with minimal hassle.

Additionally, the Company develops solutions such as smart digital contracts, NFTs SKULLYS, digital to physical assets tokenization, eXetended reality, and internet of things for everyday life.

The latest price surge came after the company, which is doing business as Santo Blockchain Labs, announced that it had purchased 50 Bitcoin ATM machines to be shipped to the company’s office in the Republic of Panama by the end of Q1 2022. The company plans to buy an additional 300 Bitcoin ATM machines this year with an investment of over $1 million.

The company’s subsidiary Santo Pay de Panama S.A. will be developing a multinational rollout plan for Panama, Colombia and Costa Rica. Besides the 300 Bitcoin ATMs, the company is working on the Santo Crypto Wallet, currently in the development stage, which will be running on the lighting layer 2 network, as well as the the deployment of the Santo Bitcoin debit card. The company CEO Frank Yglesias said:

“2022 will be a non-stop year of growth for Santo; as I personally plan for the companies’ 2022 year workload schedule. Santo is on a journey to help bring a new wave of crypto banking, investment and commerce to over 400,000,000 people in Latin America that are unbanked or unbankable, including 10%-15% of the Hispanics in USA that also are unbankable.”

The $4 million company has a decent share structure and a great growth plan for 2022, which is a great combination to attract investors. It seems that SANP is betting everything on its ATMs and crypto ecosystem, which can bring significant revenue, especially if the crypto industry revives later this year.

THE FINAL NOTE

All of the 4 OTC stocks discussed today are good stocks to hold. The upside is much greater than the downside at these levels.

It’s also very important to eye OTC stocks that have yet to make their explosive move. There are plenty of opportunities, and we take our time to monitor hundreds of penny stocks to buy each week, trying to find the best alerts for our subscribers.

Remember, all you need is one or two penny stocks to succeed in order to crush the market averages.

As always, good luck to all (except the shorts)!

WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN FINDING MOMENTUM BEFORE IT HAPPENS!

Disclosure: We have no position in any of the securities mentioned. We wrote this article ourselves and it expresses our own opinions. We are not receiving compensation for it. We have no business relationship with any company whose stock is mentioned in this article. Insider Financial is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This article is not a solicitation or recommendation to buy, sell, or hold securities. This article is meant for informational and educational purposes only and does not provide investment advice.

4 OTC Stocks to Watch This Year: ENZC HMBL ILST SANP
Click to comment
To Top
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]